Global Multiplexed Diagnostics Market: By Product (Reagents and Consumables, Analyzers), By Application (Disease Diagnostics, Molecular Diagnostics, and Drug Development), By Technology (Very High Density Multiplexed Assays, High Density Multiplexed Assays, Medium Density Multiplexed Assays, Low Density Multiplexed Assays, and Next Generation Sequencing Assays), By End User (Hospitals, Diagnostic Centers, and Research Centers), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024
Global multiplexed diagnostics market was valued at US $ XX Mn in 2017 and projected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024
Market Outline: Multiplexed Diagnostics Market
Multiplexed diagnostics are utilized as a part of examination of biological samples, which are fit for finishing a screening procedure with a solitary run. Multiplexed assay tests are engaged with the discovery and analysis of various illnesses and contaminations, which incorporate growths, immune system ailments, hypersensitivities, and cardiovascular infections.
Market Dynamics: Multiplexed Diagnostics Market
Expanding occurrence of constant sicknesses is to drive the development of the multiplexed diagnostics market. As per Cancer Research UK, around 20 instances of ovarian growths are analyzed each day and it is anticipated to increment by around 15% from 2014 to 2035. Besides, as indicated by American Cancer Society (ACS), in 2017, around 53,670 individuals are required to be determined to have pancreatic growth in the U.S. Presentation of cutting edge innovation in multiplexed diagnostics make a positive effect on understanding and is relied upon to fuel the development of the multiplexed demonstrative market. SpeeDx has gotten CE-IVD stamping for its PlexPCR VHS Multiplex qPCR innovation in October 2017. In addition, Bruker has gotten CE-IVD checking for its Fungiplex Candida symptomatic examine in October 2017. Furthermore, multiplexed diagnostics market is expanding owing to the increase in rate of broad innovative products being made to grow and broaden the current applications in multiplexed diagnostics, the improvement in bland stages, and a more prominent utilization of multiplexed diagnostics in scholarly and examine associations. However, the worldwide multiplexed diagnostics market is being controlled by high costs relating to multiplexed diagnostics test and a general absence of talented work for dealing with the equipment handling.
Market Scope: Multiplexed Diagnostics Market
Multiplexed diagnostics market is segmented based on the product, application, technology, end user and geography
Based on the product, the market is segmented into the following:
- Reagents and Consumables
Based on the technology, the market is segmented into the following:
- Very High Density Multiplexed Assays
- High Density Multiplexed Assays
- Medium Density Multiplexed Assays
- Low Density Multiplexed Assays
- Next Generation Sequencing Assays
Based on the application, the market is segmented into the following:
- Disease Diagnostics
- Molecular Diagnostics
- Drug Development
Based on the end user, the market is segmented into the following:
- Diagnostic Centres
- Research Centres
Based on Geography, the market is segmented into the following:
- North America
- Latin America
- Asia Pacific
- The Middle East and Africa.
Market Summary: Multiplexed Diagnostics Market
Multiplexed diagnostics are proficient indicative tests for the conclusion of growths, irresistible infections, and customized prescriptions. Indicative process includes test, reagents and an instrument for result screening. Regarding market measure, malady diagnostics portion drives the market because of expanded selection in the location, screening and observing of growths and irresistible illnesses. Malady diagnostics section is relied upon to develop at an impressive pace because of expanded pervasiveness of constant illnesses and intense diseases. As indicated by the information gave by CDC, around 236,968 ladies are influenced by bosom growth in the U.S. in the year 2014. Ascend in the quantity of malignancy cases has expanded the interest for multiplexed diagnostics units. High thickness and medium thickness tests are relied upon to lead the market because of higher cost productivity and reasonableness. Different elements adding to the development of the market incorporate presentation of novel items in the market. For example, Mercodia has presented AKURIO Islet Hormones measure, a multiplex which can distinguish and evaluate glucagon, insulin, C-peptide, and star insulin in asame sample.
Regional Analysis: Multiplexed Diagnostics Market
Geographically, global multiplexed diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America offering growth opportunities owing to esteem, inferable from a rising pervasiveness of cardiovascular illnesses and disease in the area. North American players in the multiplexed diagnostics market likewise profit by the more prominent level of entrance of the national medicinal services administrations. The area is required to keep commanding the worldwide multiplexed diagnostics market till 2024, a probability credited to the locale’s high level of the geriatric populace, a progressed and organized medicinal services industry, and a huge extent of use of repayment strategies from both open and private sources. In Europe, the market for multiplexed diagnostics is anticipated to develop at a considerable rate with the developing contribution of scholastic and research organizations from Germany and the U.K. North America and Europe are anticipated to be very lucrative markets for players from the worldwide multiplexed diagnostics market. On the other hand, multiplexed diagnostics have not yet discovered strong establishments in Latin America, Asia Pacific, and the Middle East and Africa to develop on for the time being.
Competition Assessment: Multiplexed Diagnostics Market
Some of the players in the global multiplexed diagnostics market include:
- Thermo Fisher Scientific, Inc. (U.S.)
- QIAGEN N.V. (Netherlands)
- Luminex Corporation (U.S.)
- Bio-Rad Laboratories(U.S.)
- Illumina, Inc. (U.S.), Inc.